These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21392916)

  • 1. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.
    Minami Y; Chung H; Kudo M; Kitai S; Takahashi S; Inoue T; Ueshima K; Shiozaki H
    AJR Am J Roentgenol; 2008 Jun; 190(6):W335-41. PubMed ID: 18492875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
    Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography.
    Hirooka M; Iuchi H; Kumagi T; Shigematsu S; Hiraoka A; Uehara T; Kurose K; Horiike N; Onji M
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S255-60. PubMed ID: 16632685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation.
    Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
    Clin Imaging; 2010; 34(1):60-4. PubMed ID: 20122522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images.
    Minami Y; Kudo M; Chung H; Inoue T; Takahashi S; Hatanaka K; Ueda T; Hagiwara H; Kitai S; Ueshima K; Fukunaga T; Shiozaki H
    Oncology; 2007; 72 Suppl 1():111-6. PubMed ID: 18087191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.
    Kisaka Y; Hirooka M; Koizumi Y; Abe M; Matsuura B; Hiasa Y; Onji M
    J Clin Ultrasound; 2010; 38(3):138-44. PubMed ID: 20014137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
    Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
    Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation.
    Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
    Hepatogastroenterology; 2011; 58(110-111):1638-42. PubMed ID: 22086693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images.
    Kim KW; Lee JM; Klotz E; Kim SJ; Kim SH; Kim JY; Han JK; Choi BI
    AJR Am J Roentgenol; 2011 May; 196(5):W565-72. PubMed ID: 21512046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Hori M; Kudo M; Murakami T
    Dig Dis; 2013; 31(5-6):485-9. PubMed ID: 24281025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma.
    Motoyama T; Ogasawara S; Chiba T; Higashide T; Yokota H; Kanogawa N; Suzuki E; Ooka Y; Tawada A; Irie R; Ochi S; Masuda Y; Uno T; Yokosuka O
    Abdom Imaging; 2014 Apr; 39(2):262-8. PubMed ID: 24346490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
    Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
    AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.